The USFDA has completed its inspection of Enzene’s manufacturing unit in Chakan, Pune, issuing six procedural observations with no data integrity issues. The outcome strengthens the company’s compliance standing in regulated markets.
Indian pharma leaders Sun Pharma and Glenmark are adopting AI in drug discovery to reduce costs, accelerate R&D timelines, and move from generics toward innovative medicines.
Entod Pharmaceuticals has introduced Colladerm, the first AI bio-engineered collagen transdermal gel serum, in the 54 th National Conference of Indian Association of Dermatologists
Sanofi Healthcare India has expanded its Hyderabad Global Capability Centre, increasing capacity to 4,500 employees. Backed by a multi-hundred-million-dollar investment, the move strengthens India’s role in Sanofi’s global operations.
Mankind Pharma has completed a multi-year transformation of its global supply chain and procurement operations, cutting stock-outs by 75% and strengthening medicine access across 25+ international markets with AI-powered planning tools.
Natco Pharma shares jumped nearly 11% after the company received CDSCO approval to manufacture and market generic Semaglutide Injection in India, boosting investor sentiment and driving heavy trading volumes.
Zydus Lifesciences has received USFDA approval for Ammonium Lactate Cream, 12%, a treatment for dry skin and ichthyosis vulgaris.
Biocon’s Q3 results show strong revenue and profit growth, led by Biosimilars and Generics. Strategic debt reduction and R&D investments position the company for robust FY27 performance.
Thermo Fisher partners with Datavant to enhance clinical research by connecting real-world data (RWD) and speeding up evidence generation for biotech and pharma companies.
Novo Nordisk is preparing to introduce Wegovy in vial format, expanding delivery options for its blockbuster weight-loss drug as competition intensifies in the fast-growing obesity treatment market.